Back to Journals » Cancer Management and Research » Volume 10

Transoral robotic surgery for oropharyngeal cancer: patient selection and special considerations

Authors Baskin RM, Boyce BJ, Amdur R, Mendenhall WM, Hitchcock K, Silver N, Dziegielewski PT

Received 10 October 2017

Accepted for publication 25 December 2017

Published 20 April 2018 Volume 2018:10 Pages 839—846


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Kenan Onel

R Michael Baskin,1 Brian J Boyce,1,2 Robert Amdur,2,3 William M Mendenhall,2,3 Kathryn Hitchcock,2,3 Natalie Silver,1,2 Peter T Dziegielewski1,2

1Department of Otolaryngology, University of Florida, Gainesville, FL, USA; 2University of Florida Health Cancer Center, Gainesville, FL, USA; 3Department of Radiation Oncology, University of Florida, Gainesville, FL, USA

Abstract: The increasing incidence of oropharyngeal squamous cell carcinoma (OPSCC) emphasizes the importance of optimizing treatment for the disease. Historical protocol has utilized definitive radiation and invasive open procedures; these techniques expose the patient to significant risks and morbidity. Transoral robotic surgery (TORS) has emerged as a therapeutic modality with promise. Here, the literature regarding proper patient selection and other considerations for this procedure was reviewed. Multiple patient and tumor-related factors were found to be relevant for successful use of this treatment strategy. Outcomes regarding early and advanced-stage OPSCC were analyzed. Finally, the literature regarding use of TORS in three distinct patient populations, individuals with primary OPSCC, carcinoma of unknown primary and those with recurrent OPSCC, was examined.

Keywords: oropharyngeal cancer, TORS, robotic surgery, carcinoma of unknown primary

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]